24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Kids With Autism Can Really Benefit From ExerciseFDA Approves First New Children's ADHD Drug in 10 YearsWhy Are ER Wait Times Getting Longer for Kids in Mental Health Crisis?About 40,000 U.S. Children Have Lost a Parent to COVID-19Is Empathy Born in Mom's First Hugs?Adding in Stem Cell Therapy Helps Beat a Common Childhood LeukemiaWhat Will Summer Camp Look Like This Year?When Will America's Kids Get Their COVID Vaccines?1 in 4 Parents Won't Vaccinate Their Kids Against COVID-19: PollEven in a Pandemic, Child Vision Tests Are CrucialPfizer Says Its COVID Vaccine Is Very Effective in Kids as Young as 12Secondhand Smoke Is Sending Kids to the ERDrug Shows Promise Against Rare Condition That Stunts Kids' GrowthWhen Coal-Fired Power Plants Close, Kids With Asthma Breathe EasierAnother Study Finds COVID Doesn't Spread in Schools With Proper SafeguardsNearly Half of U.S. Schools Now Offer In-Person LearningLockdowns Gave Boost to Type 1 Diabetes Control in KidsWildfire Smoke Can Send Kids With Asthma to the ERPandemic Has Many Kids Struggling With Weight IssuesLab-Made Heart Valves Can Grow Along With Youngest Heart PatientsSome Kids With Type 1 Diabetes Face High Risk of Severe COVID-19Virtual Learning Has Taken a Toll on Kids' & Parents' Mental HealthCDC Says 3 Feet of Social Distancing Now OK in Most ClassroomsWhich Kids' Sports Have Higher Odds for Head Injury?Social Distancing Probably Stopped 2020 Outbreak of Paralyzing Disorder in KidsAHA News: What Parents Should Know About Rare But Scary COVID-19-Related IllnessSchool Dental Care Program Could Cut Cavities in Half: StudySocial Media, Binge Eating Often Go Together for KidsStressed and Distracted, Kids and Their Teachers Say Virtual Learning Isn't WorkingSports Position Doesn't Affect Risk of Concussion-Linked CTE IllnessPandemic Putting Added Strain on Parents of Kids With CancerDogs and Kids Are 'In Sync,' Study ShowsTeachers Main Drivers of School COVID Outbreaks, So Vaccinations Needed: StudyTips to Keep Young Athletes Injury-FreeMental Illness in Childhood Could Mean Worse Physical Health Decades LaterKids' Robust Immune Systems May Shield Them From COVID-19: StudyFertility Treatments Might Affect Kids' Growth, But Not for LongMom's Heart Health While Pregnant Could Influence Her Child's Health for YearsPandemic Has Affected Kids' Dental Health: PollNew Rabies Prevention Treatment Also Works in Kids: StudyWhen Will Kids Get the COVID Vaccines?U.S. Schools Can Reopen, With Safeguards in Place: CDCFetal Surgery Is Changing Lives for Kids With Spina BifidaKids Who Got Flu Shot Had Milder COVID Symptoms: StudyVery Little Spread of Coronavirus at Kids' Day Camps: StudyWhen Kids Misbehave, 'Verbal Reasoning' Can Sometimes BackfireVaccines Saved 37 Million Lives, Mostly Children, Over Past Two DecadesAnchor It! Toppling TVs, Furniture Can Injure and Kill KidsWhy Do Black Children Get Fewer Scans When They're Seen in ERs?Pandemic May Be Affecting How Parents Feed Their Kids
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

FDA Approves First New Children's ADHD Drug in 10 Years

HealthDay News
by Robin Foster
Updated: Apr 6th 2021

new article illustration

TUESDAY, April 6, 2021 (HealthDay News) -- The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration.

Qelbree, also known as viloxazine, comes in a capsule that is taken daily, and is not a stimulant. This makes it harder to abuse than older ADHD drugs, nearly all of which contain the stimulants amphetamine or methylphenidate.

Experts say the drug may appeal to parents who don't want to give their child stimulants.

It also could be an option for kids who already have substance abuse problems, dislike the side effects of stimulants or need additional therapy, Dr. David Goodman told the Associated Press. He's an assistant professor of psychiatry at Johns Hopkins School of Medicine in Baltimore.

Goodman said most ADHD patients are prescribed long-acting stimulants, which are harder to abuse to get a high than the original, fast-acting versions of these drugs. Developed by Supernus Pharmaceuticals of Rockville, Md., Qelbree carries a warning about the potential for suicidal thoughts and behavior, which occurred in fewer than 1% of volunteers in studies of the drug, the AP said.

Supernus wouldn't disclose the drug's list price, but it's sure to be higher than the many cheap generic ADHD pills on the market today, the AP said.

ADHD affects about 6 million American children and adolescents, according to the U.S. Centers for Disease Control and Prevention. For many, problems include trouble paying attention and completing tasks, fidgeting and impulsiveness.

In a late-stage study funded by Supernus, 477 children aged 6 to 11 took the drug for six weeks. Inattention and hyperactivity symptoms were reduced by about 50% compared to the placebo group, the AP reported. Qelbree helped reduce symptoms in some study volunteers within a week. Common side effects included sleepiness, lethargy, decreased appetite and headache.

Supernus is in late-stage testing of Qelbree for adults with ADHD, the AP said. It's in a much smaller group than children, but that market is growing because few adults currently take ADHD medicines.

Viloxazine was sold as an antidepressant in Europe for several decades, but was never approved by the FDA, the AP reported. The maker ended sales for business reasons nearly two decades ago, as popular pills such as Zoloft and Prozac came to dominate the market.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on ADHD.

SOURCE: Associated Press